Cargando...
ST2: the biomarker at the heart of GVHD severity
In this issue of Blood, Ponce et al report that high suppression of tumorigenicity 2 (ST2) levels are significantly associated with the incidence of acute graft-versus-host disease (aGVHD) and transplant-related mortality (TRM) in recipients of double-unit cord blood transplants (CBTs).(1)
Guardado en:
| Publicado en: | Blood |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Hematology
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4281822/ https://ncbi.nlm.nih.gov/pubmed/25554746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-11-611780 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|